Literature DB >> 22123421

Update on photodermatoses.

Frank A Santoro1, Henry W Lim.   

Abstract

Interactions with ultraviolet radiation (UVR) and chromophores in the skin happen on a daily basis. Photodermatoses, which are abnormal responses to UV exposure, can be classified into subgroups based on pathogenesis. This review will discuss the clinical features, pathogenesis, photobiologic evaluation, prognosis and therapies of the most common photodermatoses.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh：

Year:  2011        PMID： 22123421     DOI： 10.1016/j.sder.2011.07.007

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN： 1085-5629


  5 in total

1.  [Phototoxic and photoallergic reactions].

Authors:  N J Neumann; S Schauder
Journal:  Hautarzt       Date:  2013-05       Impact factor: 0.751

Review 2.  Visible light. Part II: Photoprotection against visible and ultraviolet light.

Authors:  Amaris N Geisler; Evan Austin; Julie Nguyen; Iltefat Hamzavi; Jared Jagdeo; Henry W Lim
Journal:  J Am Acad Dermatol       Date:  2021-02-25       Impact factor: 11.527

3.  Photobinding of Triflusal to Human Serum Albumin Investigated by Fluorescence, Proteomic Analysis, and Computational Studies.

Authors:  Oscar Molins-Molina; Raúl Pérez-Ruiz; Emilio Lence; Concepción González-Bello; Miguel A Miranda; M Consuelo Jiménez
Journal:  Front Pharmacol       Date:  2019-09-20       Impact factor: 5.810

4.  In vitro Assessment of Solar Filters for Erythropoietic Protoporphyria in the Action Spectrum of Protoporphyrin IX.

Authors:  Alvise Sernicola; Elena Cama; Maria Guglielmina Pelizzo; Enrico Tessarolo; Annamaria Nicolli; Giulia Viero; Mauro Alaibac
Journal:  Front Med (Lausanne)       Date:  2021-12-20

Review 5.  NRF2 in dermatological disorders: Pharmacological activation for protection against cutaneous photodamage and photodermatosis.

Authors:  Shirin Kahremany; Lukas Hofmann; Arie Gruzman; Albena T Dinkova-Kostova; Guy Cohen
Journal:  Free Radic Biol Med       Date:  2022-06-23       Impact factor: 8.101
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.